Title : Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.

Pub. Date : 2012 Jul-Aug

PMID : 22534478






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: p53 expression were associated with the significantly shorter disease-free survival (DFS) (p<0.001) and overall survival (OS) (p=0.012) in the curatively resected advanced gastric cancer patients receiving capecitabine plus paclitaxel. Paclitaxel tumor protein p53 Homo sapiens
2 CONCLUSIONS: p53 expression positive might predict prognosis in gastric cancer patients who underwent curative surgery followed by adjuvant capecitabine plus paclitaxel chemotherapy. Paclitaxel tumor protein p53 Homo sapiens
3 A favorable effect of capecitabine plus paclitaxel might therefore be expected in patients that do not express p53. Paclitaxel tumor protein p53 Homo sapiens